Scholars Central

Brief reportPublished 31 Jan 2025

Association between MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients

Authors: Dnako Junashi

Journal of Nephrology & Therapeutics

Volume 15 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

MOTS-c, a mitochondrial-derived peptide, has garnered significant attention for its role in metabolic regulation, cellular homeostasis, and muscle maintenance. In chronic peritoneal dialysis patients, the risk of sarcopenia is particularly high due to multiple contributing factors, including chronic inflammation, oxidative stress, malnutrition, and prolonged exposure to uraemic toxins. Sarcopenia, characterized by progressive loss of muscle mass and function, significantly affects morbidity and mortality in dialysis patients. Understanding the association between MOTS-c levels and sarcopenia risk could provide valuable insights into potential therapeutic interventions and early diagnostic markers.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nephrology & Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nephrology & Therapeutics
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Dnako Junashi”